Answers are grounded in this paper and cite their sources.
Case report shows VZV encephalitis in a healthy traveler, suggesting need for awareness and antiviral therapy.
The varicella-zoster virus (VZV) is one of the main etiologies of encephalitis in adults, especially in elderly and immunocompromised individuals. Its occurrence in young immunocompetent patients, particularly without cutaneous manifestations, is rare. This study reports the case of a 35-year-old previously healthy man who developed VZV encephalitis during prolonged travel through Latin America, without associated exanthema.The patient traveled through Argentina, Uruguay, Chile, Bolivia, Peru, Ecuador, Colombia, Panama, the Dominican Republic, Costa Rica, and Nicaragua between January and November 2023. During the journey, he presented self-limited episodes of diarrhea, without systemic signs or need for antibiotics. In early November, he sought medical care due to left-sided bitemporal and suboccipital headache, pulsatile, insidious, daily, with progressive worsening over the previous five days, associated with paresthesia in the lower limbs and language disturbances (paraphasias). He denied fever, seizures, paresis, ataxia, or systemic symptoms. On physical examination, only language alterations were observed. No cutaneous lesions were present. Magnetic resonance imaging showed hyperintensity in the right frontobasal subcortical white matter. Cerebrospinal fluid analysis revealed hypoglycorrhachia (32.7 mg/dL), hyperproteinorrhachia (122.01 mg/dL), and hyperlactatorrhachia (34.86 mg/dL). A molecular panel (multiplex PCR) identified VZV DNA, while all other tested pathogens were negative (Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, cytomegalovirus, enterovirus, human herpesvirus type 6, herpes simplex virus type 2, human parechovirus, and Cryptococcus neoformans/gattii). Intravenous acyclovir was initiated for eight days, followed by oral acyclovir for six additional days. The patient evolved with complete resolution of symptoms, without residual deficits. Follow-up MRI showed normal findings. Investigation for possible immunodeficiencies, including HIV testing, lymphocyte immunophenotyping, and immunoglobulin and complement levels, was negative. As a prophylactic measure, the patient was advised to receive vaccination against herpes zoster with a recombinant inactivated vaccine. This case highlights an atypical presentation of VZV encephalitis in a young immunocompetent individual without cutaneous manifestations. It reinforces the importance of molecular testing in the etiological investigation of acute neurological syndromes and the early initiation of antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Bomfim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: